ethyl (E)-3-(4-amino-3-hydroxyphenyl)-2-methylprop-2-enoate

• 分子结构分类: 有机化合物 - 苯丙烷和聚酮 - 肉桂酸及其衍生物
• 英文名称: ethyl (E)-3-(4-amino-3-hydroxyphenyl)-2-methylprop-2-enoate
• 化学式: C₁₂H₁₅NO₃
• 分子量: 221.25
• InChiKey: AITIQIFYYFYBOF-SOFGYWHQSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.9
• 重原子数：
  16
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.25
• 拓扑面积：
  72.6
• 氢给体数：
  2
• 氢受体数：
  4

文献信息

• [EN] THROMBOPOIETIN MIMETICS<br/>[FR] MIMETIQUES DE LA THROMBOPOIETINE
  申请人：SMITHKLINE BEECHAM CORP

  公开号：WO2003103686A1

  公开（公告）日：2003-12-18

  Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy­1-azobenzene derivative.

  发明了非肽类TPO拟物。还发明了用于制备目前发明的化合物的新工艺和中间体。还发明了一种治疗血小板减少症的方法，包括给予需要的哺乳动物，包括人类，有效量的选定羟基-1-偶氮苯衍生物。
• Thrombopoietin mimetics
  申请人：Heerding A. Dirk

  公开号：US20050234020A1

  公开（公告）日：2005-10-20

  Invented are non-peptide TPO mimetics. Also invented are novel processes and intermediates used in the preparation of the presently invented compounds. Also invented is a method of treating thrombocytopenia, in a mammal, including a human, in need thereof which comprises administering to such mammal an effective amount of a selected hydroxy-1-azobenzene derivative.

  本文介绍了一种非肽类TPO类似物的发明。还发明了用于制备该类化合物的新型工艺和中间体。同时，发明了一种治疗血小板减少症的方法，该方法包括向需要治疗的哺乳动物（包括人类）中注入所选的羟基-1-偶氮苯衍生物的有效剂量。
• THROMBOPOIETIN MIMETICS
  申请人：Smithkline Beecham

  公开号：EP1556059A1

  公开（公告）日：2005-07-27
• US7414040B2
  申请人：——

  公开号：US7414040B2

  公开（公告）日：2008-08-19